Magnesiiumsulfaat Teva

Magnesium sulfate, the active ingredient in Magnesiiumsulfaat Teva, is an electrolyte presented as a sterile solution for intra‑articular, intravenous and peri‑articular use. It is employed to correct magnesium deficiency and to manage obstetric, cardiac and respiratory emergencies in appropriate patient populations.

GNH USA supplies Magnesiiumsulfaat Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnesium sulfate is employed in several electrolyte‑related and obstetric conditions.

- Hypomagnesemia: restores normal serum magnesium concentrations. - Eclampsia and preeclampsia: prevents seizures in pregnant women with severe hypertension. - Torsades de pointes: stabilises cardiac repolarisation to terminate ventricular arrhythmia. - Severe asthma exacerbations: provides bronchodilatory support as an adjunct therapy. - Intra‑articular injection for joint pain: reduces inflammation and alleviates pain in affected joints.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Flushing or warmth at the injection site - Nausea or vomiting - Headache - Mild hypotension - Sweating - Transient muscle weakness

Serious or Rare Side Effects: - Severe hypotension or cardiovascular collapse - Respiratory depression - Cardiac arrest or severe arrhythmias - Anaphylactic or severe allergic reactions - Hypermagnesemia with neuromuscular paralysis - Tissue necrosis or severe irritation at the injection site

Magnesium sulfate requires careful assessment of patient risk factors before administration.

- Renal impairment: monitor serum magnesium and adjust dose. - Cardiovascular disease: observe for profound hypotension. - Neuromuscular disorders: risk of increased muscle weakness. - Pregnancy: use only when clearly indicated and benefits outweigh potential risks. - Concomitant medications: review for interactions that may potentiate effects. - Store at below 25°C: keep in original container, protect from moisture and direct sunlight.

Magnesium sulfate can modify the activity of several co‑administered drugs.

Major Interactions (Avoid): - Calcium channel blockers: additive hypotensive effect. - Neuromuscular blocking agents: prolonged paralysis. - Digoxin: increased risk of arrhythmia. - Loop diuretics: may exacerbate magnesium loss leading to imbalance. - Quinidine: heightened risk of cardiac conduction disturbances.

Moderate Interactions (Monitor Closely): - Aminoglycoside antibiotics: enhanced neuromuscular blockade. - ACE inhibitors: increased chance of hypermagnesemia. - NSAIDs: reduced renal clearance of magnesium. - β‑agonists: possible attenuation of bronchodilatory benefit. - Oral antacids containing magnesium: additive magnesium load.